Dr. Krajcer is a member of the Texas Heart Institute’s Professional Staff Leadership team and serves as the Director of Peripheral Vascular Disease. He is an active member of the Texas Heart Institute Cardiovascular Disease Fellowship Program at Baylor St. Luke’s Medical Center teaching staff, training our next generation of physician-scientists and interventional cardiologists. His leadership and commitment to important international research and education collaborations are impacting the care of patients suffering from vascular diseases worldwide. Dr. Krajcer is an internationally recognized pioneer in his field and serves as the President of the International Society for Endovascular Specialist dedicated to the advancement of vascular and endovascular therapies.
Since 1996, Dr. Krajcer has participated as a co-investigator and principal investigator in many clinical trials for treatment of peripheral arterial disease, abdominal and thoracic aortic aneurysms and carotid artery stenosis including Corvita AAA trial, Hemobahn Trial, AneuRx AAA Trial, AneuRx Thoracic trial, Wallgraft Trial, Carotid Wallstent Trial, Sapphire Carotid Stent Trial, BEECH Carotid Trial, Sapphire World Registry Trial, Archer Carotid Stent Trial, Choice Carotid stent Trial, Capture I & II Carotid Stent Trials, Endologix EVAR Trials, Valor I and Valor II Trial, Captivia Thoracic Trial, Captivia Acute Dissection Trial, and Excluder Original Design vs. Low Permeability Design study.